Results 151 to 160 of about 73,750 (259)

Uremia and parathyroid hormone have distinct effects on bone protein and gene expression. [PDF]

Kidney Int
Wagner CS, Elias RM, Nickolas TL, Martin A, Martinez-Calle M, Oliveira IB, Coelho AC, Dos Reis LM, Jorgetti V, David V, Moysés RMA.   +10 more
europepmc   +1 more source

Associations between Serum Zinc Levels and the Presence of Distal Symmetric Polyneuropathy in Patients with Type 2 Diabetes Mellitus

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 4, July 2026.
Lower serum zinc levels were independently associated with distal symmetric polyneuropathy in patients with type 2 diabetes mellitus. Each 1 μg/dL increase in serum zinc level was associated with a 5.4% reduction in the odds of diabetic neuropathy, suggesting a potential role of zinc deficiency in DSPN pathogenesis.
Hosseinali Mohammadi, Firozeh Sajedi, Younes Mohammadi   +2 more
wiley   +1 more source

Impact of Clinoptilolite and Anionic Salts on Calcium Homeostasis, Parathyroid Hormone, and Related Metabolic Parameters in Periparturient Dairy Cows. [PDF]

Vet Sci
Huang P, Su X, Guo Y, Ma C, Cao J.
europepmc   +1 more source

Effects of Synbiotic Supplementation on Bone Turnover Markers in Kidney Transplant Recipients: A Randomized Controlled Trial

Food Science &Nutrition, Volume 14, Issue 7, July 2026.
This study shows that synbiotic supplementation for 12 weeks decreases serum C‐telopeptide, a marker of bone resorption, and increases serum osteocalcin, a marker of bone formation, in KT recipients. ABSTRACT Bone disorders are common in kidney transplant (KT) recipients. This research explores the impact of synbiotic supplementation on markers related
Zeinab Karimi, Hadi Tabibi, Mohsen Nafar, Shiva Samavat, Ahmad Firouzan, Mehdi Hedayati   +5 more
wiley   +1 more source

Nonlinear relationship between circulating homocysteine and parathyroid hormone among patients with osteoporotic fractures: A cross-sectional study based on a hospital cohort. [PDF]

PLoS One
Wang JH, Wang WH, He DW, Lu K, Li C, Hao YM.   +5 more
europepmc   +1 more source

Vitamin D Pretreatment to Prevent the Risk of Postoperative Hypocalcemic Complications After Parathyroidectomy in Primary Hyperparathyroidism: A Systematic Review and Meta‐Analysis

Head &Neck, Volume 48, Issue 7, Page 1865-1875, July 2026.
ABSTRACT Background Parathyroidectomy is the treatment for primary hyperparathyroidism, yet postoperative hypocalcemia and hungry bone syndrome remain common. Vitamin D deficiency has been suggested as a modifiable risk factor, but evidence supporting preoperative supplementation is inconsistent.
Matthew Gynn, Helia Mansouri Dana, Oleksandr Butskiy   +2 more
wiley   +1 more source

Elevated parathyroid hormone levels in normocalcemic patients after parathyroidectomy for primary hyperparathyroidism: what risk factors should be considered? [PDF]

BMC Endocr Disord
Yang J, He Z, Zhou P, Lu X, Weng W, Ding C, Wang H, Su X.   +7 more
europepmc   +1 more source

Analytical and Workflow Performance of a High‐Throughput Chemiluminescent Immunoassay System in a Clinical Laboratory

Journal of Clinical Laboratory Analysis, Volume 40, Issue 13, July 2026.
Analytical and operational performance evaluation of the DxI 9000 Access Immunoassay Analyzer in a clinical laboratory in Taiwan. ABSTRACT Background Increasing test volumes and shorter turnaround time (TAT) requirements, particularly in acute‐care settings, challenge clinical laboratories to maintain accurate immunoassay testing.
Chiung‐Tzu Hsiao, Chao‐Ching Liao, Yu‐Chang Chang, Hui‐Ju Chang, Tz‐Ya Huang, Jen‐Shiou Lin, Po‐Ren Hsueh   +6 more
wiley   +1 more source

Immune Dysregulation in Branched Chain Organic Acidemias

Journal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT Organic acidemias (OAs) are a group of inherited disorders, most commonly caused by defects in mitochondrial enzymes involved in amino acid and fatty acid metabolism. While they characteristically present with metabolic and neurological crises, growing evidence reveals a significant burden of chronic immune dysregulation in some disorders and ...
Abdul L. Shakerdi, Jack Drda, Justin A. Dutta, Jerry Vockley   +3 more
wiley   +1 more source

First Reported Use of Recombinant Parathyroid Hormone in Kenny-Caffey Syndrome Type 2: A Case Report and Literature Review. [PDF]

Diseases
Djordjevic Milosevic M, Skakic A, Andjelkovic M, Delgado-Vega AM, Thonberg H, Klaassen K, Komazec J, Kecman B, Jocic N, Björck E, Lindstrand A, Stojiljkovic M.   +11 more
europepmc   +1 more source